SNHG22 and cancer: To date, there are 22 members of the SNHG family (SNHG1 to SNHG22) many of which have been shown to be deregulated in cancer, being critically involved in processes such as cancer cell proliferation, tumor progression, metastasis, and chemoresistance [4].